198 related articles for article (PubMed ID: 34681024)
1. Marek's Disease Virus Telomeric Integration Profiles of Neoplastic Host Tissues Reveal Unbiased Chromosomal Selection and Loss of Cellular Diversity during Tumorigenesis.
Glass MC; Smith JM; Cheng HH; Delany ME
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681024
[TBL] [Abstract][Full Text] [Related]
2. Vaccination and Host Marek's Disease-Resistance Genotype Significantly Reduce Oncogenic Gallid alphaherpesvirus 2 Telomere Integration in Host Birds.
McPherson MC; Cheng HH; Smith JM; Delany ME
Cytogenet Genome Res; 2018; 156(4):204-214. PubMed ID: 30572327
[TBL] [Abstract][Full Text] [Related]
3. Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.
Burgess SC; Davison TF
J Virol; 2002 Jul; 76(14):7276-92. PubMed ID: 12072527
[TBL] [Abstract][Full Text] [Related]
4. Characterization of integrated Marek's disease virus genomes supports a model of integration by homology-directed recombination and telomere-loop-driven excision.
Wood ML; Neumann R; Roy P; Nair V; Royle NJ
J Virol; 2023 Oct; 97(10):e0071623. PubMed ID: 37737586
[TBL] [Abstract][Full Text] [Related]
5. Telomeres and Telomerase: Role in Marek's Disease Virus Pathogenesis, Integration and Tumorigenesis.
Kheimar A; Previdelli RL; Wight DJ; Kaufer BB
Viruses; 2017 Jul; 9(7):. PubMed ID: 28677643
[TBL] [Abstract][Full Text] [Related]
6. A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.
Lian L; Qu L; Chen Y; Lamont SJ; Yang N
PLoS One; 2012; 7(11):e51003. PubMed ID: 23226446
[TBL] [Abstract][Full Text] [Related]
7. Latency and tumorigenesis in Marek's disease.
Nair V
Avian Dis; 2013 Jun; 57(2 Suppl):360-5. PubMed ID: 23901747
[TBL] [Abstract][Full Text] [Related]
8. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation.
Li X; Lian L; Zhang D; Qu L; Yang N
Poult Sci; 2014 May; 93(5):1097-105. PubMed ID: 24795301
[TBL] [Abstract][Full Text] [Related]
9. Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits
Zhang Y; Li W; Tang N; Moffat K; Nair V; Yao Y
J Virol; 2022 Mar; 96(6):e0202721. PubMed ID: 35107377
[TBL] [Abstract][Full Text] [Related]
10. Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype.
Burgess SC; Basaran BH; Davison TF
Vet Pathol; 2001 Mar; 38(2):129-42. PubMed ID: 11280369
[TBL] [Abstract][Full Text] [Related]
11. Induction of DNA Damages upon Marek's Disease Virus Infection: Implication in Viral Replication and Pathogenesis.
Bencherit D; Remy S; Le Vern Y; Vychodil T; Bertzbach LD; Kaufer BB; Denesvre C; 
